Literature DB >> 15735244

Recovery from anti-recombinant-human-erythropoietin associated pure red cell aplasia in end-stage renal disease patients after renal transplantation.

Kearkiat Praditpornsilpa1, Somphon Buranasot, Narudee Bhokaisuwan, Yingyos Avihingsanon, Trairak Pisitkul, Talerngsak Kansanabuch, Somchai Eiam-Ong, Sauwaluck Chusil, Tanin Intarakumtornchai, Kriang Tungsanga.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15735244     DOI： 10.1093/ndt/gfh666

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  2 in total

1.  Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Research on Adverse Drug Events and Reports (RADAR) Project.

Authors:  Charles L Bennett; Denis Cournoyer; Kenneth R Carson; Jerome Rossert; Stefano Luminari; Andrew M Evens; Francesco Locatelli; Steven M Belknap; June M McKoy; E Alison Lyons; Benjamin Kim; Rishi Sharma; Stacey Costello; Edwin B Toffelmire; George A Wells; Hans A Messner; Paul R Yarnold; Steven M Trifilio; Dennis W Raisch; Timothy M Kuzel; Allen Nissenson; Lay-Cheng Lim; Martin S Tallman; Nicole Casadevall
Journal:  Blood       Date:  2005-08-11       Impact factor: 22.113

2.  A 46-Year-Old Thai Woman with Secondary Acquired Pure Red Cell Aplasia Due to Treatment with Recombinant Erythropoietin While on Dialysis for End-Stage Renal Disease Who Recovered Following ABO-Incompatible Kidney Transplantation.

Authors:  Rungthiwa Kitpermkiat; Sansanee Thotsiri; Nuttaporn Arpornsujaritkun; Premsant Sangkum; Pichika Chantrathammachart; Pimpun Kitpoka; Duangtawan Thammanichanond; Tanist Virankabutra; Surasak Kantachuvesiri
Journal:  Am J Case Rep       Date:  2022-07-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.